Anavex Life Sciences Corp. (AVXL) vs Protara Therapeutics, Inc. (TARA)
A side-by-side comparison of Anavex Life Sciences Corp. and Protara Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVXL
Anavex Life Sciences Corp.
$1.61HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
TARA
Protara Therapeutics, Inc.
$2.55HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — AVXL vs TARA
growth of $100 · dividends reinvested · last 10yAVXL -56.2% (-7.9%/yr)TARA -99.3% (-38.8%/yr)AVXL compounded faster over this window
Log scale — wide-divergence pair
AVXL TARA
AVXL vs TARA: by the numbers
- •AVXL is the larger company ($149M vs $143M market cap).
Metrics side by side
Valuation
| Metric | AVXL | TARA |
|---|---|---|
| P/B ratio | 1.32 | 0.89 |
Profitability
| Metric | AVXL | TARA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -21.38% | -43.40% |
| ROIC | -27.25% | -47.18% |
Growth (annualized)
| Metric | AVXL | TARA |
|---|---|---|
| Total return CAGR (5Y) | -37.74% | -16.45% |
Frequently asked
- How have AVXL and TARA total returns compared?
- Over the past 10 years, AVXL delivered -7.93% and TARA delivered -38.82% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.